❤️Conditions & CareErectile Dysfunction Medication Mirodenafil Yields Mixed Results in Phase III Alzheimer's Trial
An oral phosphodiesterase-5 inhibitor originally approved for erectile dysfunction missed its main overall goal in a major Alzheimer's study, though a specific subgroup s…
